| Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial G Senti, BM Prinz Vavricka, I Erdmann, MI Diaz, R Markus, SJ McCormack, ... Proceedings of the National Academy of Sciences 105 (46), 17908-17912, 2008 | 426 | 2008 |
| Multicolour spectral karyotyping of mouse chromosomes M Liyanage, A Coleman, S Manoir, T Veldman, S McCormack, ... Nature genetics 14 (3), 312-315, 1996 | 354 | 1996 |
| Apparatus and method for delivering therapeutic and/or other agents to the inner ear and to other tissues T Lobl, S McCormack, T Lenarz, J Schloss, A Nagy, J Pananen US Patent App. 11/337,815, 2006 | 299 | 2006 |
| Mechanism of interferon action: identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2α protein kinase SJ McCormack, DC Thomis, CE Samuel Virology 188 (1), 47-56, 1992 | 218 | 1992 |
| Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus … SJ McCormack, SE Brazinski, BA Werness, DJ Goldstein Oncogene 15 (3), 265-274, 1997 | 123 | 1997 |
| Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability SJ McCormack, Z Weaver, S Deming, G Natarajan, J Torri, MD Johnson, ... Oncogene 16 (21), 2755-2766, 1998 | 112 | 1998 |
| Mechanism of interferon action motif I of the interferon-induced, RNA-dependent protein kinase (PKR) is sufficient to mediate RNA-binding activity SJ McCormack, LG Ortega, JP Doohan, CE Samuel Virology 198 (1), 92-99, 1994 | 108 | 1994 |
| A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV‐cmyc transgenic mice ZA Weaver, SJ McCormack, M Liyanage, S du Manoir, A Coleman, ... Genes, Chromosomes and Cancer 25 (3), 251-260, 1999 | 104 | 1999 |
| The licensing of DNA patents by US academic institutions: an empirical survey L Pressman, R Burgess, RM Cook-Deegan, SJ McCormack, I Nami-Wolk, ... Nature Biotechnology 24 (1), 31-39, 2006 | 79 | 2006 |
| Mechanism of interferon action: biochemical and genetic evidence for the intermolecular association of the RNA-dependent protein kinase PKR from human cells LG ORTEGA, MD MCCOTTER, GL HENRY, SJ MCCORMACK, ... Virology 215 (1), 31-39, 1996 | 77 | 1996 |
| Mechanism of interferon action: RNA-binding activity of full-length and R-domain forms ofthe RNA-dependent protein kinase PKR—Determination of KD values for VAI and TAR RNAs SJ McCormack, CE Samuel Virology 206 (1), 511-519, 1995 | 59 | 1995 |
| Patents, secrecy, and DNA RM Cook-Deegan, SJ McCormack Science 293 (5528), 217-217, 2001 | 54 | 2001 |
| Apparatus and method for delivery of therapeutic and other types of agents TJ Lobl, SJ McCormack, AI Nagy, JE Pananen, JV Schloss US Patent 8,267,905, 2012 | 53 | 2012 |
| Cochlear implant with localized fluid transport WV Harrison, TJ Lobl, SJ McCormack US Patent App. 11/387,206, 2011 | 48 | 2011 |
| Characterization of the heparin-mediated activation of PKR, the interferon-inducible RNA-dependent protein kinase CX George, DC Thomis, SJ McCormack, CM Svahn, CE Samuel Virology 221 (1), 180-188, 1996 | 45 | 1996 |
| Mechanism of interferon action. Translational control and the RNA-dependent protein kinase (PKR): antagonists of PKR enhance the translational activity of mRNAs that include a … GL Henry, SJ McCormack, DC Thomis, CE Samuel Journal of biological regulators and homeostatic agents 8 (1), 15-24, 1994 | 25 | 1994 |
| An historical perspective on genomic technologies DJ Galas, SJ McCormack Current issues in molecular biology 5 (4), 123-128, 2003 | 23 | 2003 |
| Gacyclidine formulations T Lobl, J Schloss, S McCormack, A Nagy, J Pananen US Patent App. 11/367,720, 2006 | 22 | 2006 |
| Modulation of allergic response TM Kündig, SJ McCormack US Patent 6,773,695, 2004 | 21 | 2004 |
| Evaluation of changes in breast cells using nipple aspirate fluid BR Haddad, RB Dickson, SJ McCormack US Patent 6,316,189, 2001 | 18 | 2001 |
